Data sourced:
2022.
Page updated:
2026-02-16
In Panama, Nicotine Replacement Therapy (NRT) is banned. NRT products are not included on the country’s essential drugs list, and the government does not cover the cost of NRT. Despite the ban, the market size value for NRT in Panama was estimated to be 0.4 million € in 2019.
Product promotion
0.4 million €
1
2019
References:
- Consumer Health: Euromonitor from trade sources/national statistics. Date Exported: 8/9/2019. (c) Euromonitor International 2019
Regulation
Banned
1
2022
References:
- WHO report on the global tobacco epidemic, 2023. Available at: https://cdn.who.int/media/docs/default-source/country-profiles/tobacco/gtcr-2023/tobacco-2023-pan.pdf?sfvrsn=faaab816_3&download=true. Accessed: 11 January 2026.
Availability
No
1
2022
| Year | Value | Reference/Comment |
|---|---|---|
| 2019 | Yes | 1A |
| 2022 | No | 1B |
References:
- WHO Report on the Global Tobacco Epidemic 2019. https://www.who.int/tobacco/global_report/en/ (2019).
- WHO report on the global tobacco epidemic, 2023. Available at: https://cdn.who.int/media/docs/default-source/country-profiles/tobacco/gtcr-2023/tobacco-2023-pan.pdf?sfvrsn=faaab816_3&download=true. Accessed: 11 January 2026.
| Year | Value | Reference/Comment |
|---|---|---|
| 2019 | Yes | 1A |
| 2022 | No | 1B |
References:
- WHO Report on the Global Tobacco Epidemic 2019. https://www.who.int/tobacco/global_report/en/ (2019).
- WHO report on the global tobacco epidemic, 2023. Available at: https://cdn.who.int/media/docs/default-source/country-profiles/tobacco/gtcr-2023/tobacco-2023-pan.pdf?sfvrsn=faaab816_3&download=true. Accessed: 11 January 2026.
| Year | Value | Reference/Comment |
|---|---|---|
| 2019 | Pharmacy | 1A |
| 2022 | None | 1B |
References:
- WHO Report on the Global Tobacco Epidemic 2019. https://www.who.int/tobacco/global_report/en/ (2019).
- WHO report on the global tobacco epidemic, 2023. Available at: https://cdn.who.int/media/docs/default-source/country-profiles/tobacco/gtcr-2023/tobacco-2023-pan.pdf?sfvrsn=faaab816_3&download=true. Accessed: 11 January 2026.
References:
- WHO report on the global tobacco epidemic, 2023. Available at: https://cdn.who.int/media/docs/default-source/country-profiles/tobacco/gtcr-2023/tobacco-2023-pan.pdf?sfvrsn=faaab816_3&download=true. Accessed: 11 January 2026.
- WHO Report on the Global Tobacco Epidemic 2019. https://www.who.int/tobacco/global_report/en/ (2019).
Formal support
No NRT is on the country's essential drugs list.
1
2022
References:
- WHO report on the global tobacco epidemic, 2023. Available at: https://cdn.who.int/media/docs/default-source/country-profiles/tobacco/gtcr-2023/tobacco-2023-pan.pdf?sfvrsn=faaab816_3&download=true. Accessed: 11 January 2026.
Publications
The FCTC COP10 Agenda and supporting documents: implications for the future of tobacco harm reduction
Our latest Briefing Paper looks ahead to the upcoming COP10 meeting in Panama and assesses what the Agenda could mean for the future availability of the safer nicotine products that underpin tobacco harm reduction.
The Framework Convention on Tobacco Control (FCTC) and the Conference of the Parties (COP): an explainer (updated April 2023)
With the Tenth Meeting of the Conference of the Parties (COP) to the Framework Convention on Tobacco Control (FCTC) taking place in November 2023, here's our updated guide to explain how the meeting works. Scroll down to access this document in multiple languages.
The GSTHR database is updated regularly by our team.
However, please be aware that the information we provide does not constitute legal advice.
We cannot guarantee that the information is up to date or accurate, as the regulatory status of different product
categories can change at short notice and with little publicity.
If you wish to check the legal status of use or possession of any safer nicotine product in a specific country or region,
you should verify the information independently.
If you have reason to think that the information supplied on the GSTHR is inaccurate, please contact us with details
and any references and we will rectify any errors.